Therapeutic experience with ticarcillin disodium plus potassium clavulanate in the Federal Republic of Germany--results of a multicentre-study.
Three hundred and eighty protocols of a multicentre study of ticarcillin plus clavulanic acid were evaluated. Patients with a multitude of severe infections were treated. Therapy with the drug combination was successful in 89% of the cases. The drug was tolerated very well. No severe adverse reactions were attributable to the test drug.